These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 22569473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
    Duret C, Merlos R, Wauthoz N, Sebti T, Vanderbist F, Amighi K.
    Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
    [Abstract] [Full Text] [Related]

  • 4. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
    Carvalho SR, Watts AB, Peters JI, Liu S, Hengsawas S, Escotet-Espinoza MS, Williams RO.
    Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
    [Abstract] [Full Text] [Related]

  • 5. Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.
    Tolman JA, Nelson NA, Son YJ, Bosselmann S, Wiederhold NP, Peters JI, McConville JT, Williams RO.
    Eur J Pharm Biopharm; 2009 May; 72(1):199-205. PubMed ID: 19348016
    [Abstract] [Full Text] [Related]

  • 6. Dose tolerability of chronically inhaled voriconazole solution in rodents.
    Tolman JA, Nelson NA, Bosselmann S, Peters JI, Coalson JJ, Wiederhold NP, Williams RO.
    Int J Pharm; 2009 Sep 08; 379(1):25-31. PubMed ID: 19524030
    [Abstract] [Full Text] [Related]

  • 7. Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.
    Moon C, Watts AB, Lu X, Su Y, Williams RO.
    Mol Pharm; 2019 May 06; 16(5):1799-1812. PubMed ID: 30925839
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.
    Wang YB, Watts AB, Peters JI, Liu S, Batra A, Williams RO.
    AAPS PharmSciTech; 2014 Aug 06; 15(4):981-93. PubMed ID: 24824172
    [Abstract] [Full Text] [Related]

  • 9. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA, Kuhn DM.
    Eur J Med Res; 2002 May 31; 7(5):242-56. PubMed ID: 12069915
    [Abstract] [Full Text] [Related]

  • 10. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W, Tam J, Miller DA, Zhou J, McConville JT, Johnston KP, Williams RO.
    Int J Pharm; 2008 Sep 01; 361(1-2):177-88. PubMed ID: 18556158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.
    Duret C, Wauthoz N, Merlos R, Goole J, Maris C, Roland I, Sebti T, Vanderbist F, Amighi K.
    Eur J Pharm Biopharm; 2012 Aug 01; 81(3):627-34. PubMed ID: 22538097
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q, Yip L, Chow MYT, Chow SF, Chan HK, Kwok PCL, Lam JKW.
    Int J Pharm; 2019 Apr 05; 560():144-154. PubMed ID: 30731259
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR, Najvar LK, Vallor AC, Wiederhold NP, Bocanegra R, Pfeiffer J, Perkins K, Kugler AR, Sweeney TD, Patterson TF.
    J Antimicrob Chemother; 2012 Apr 05; 67(4):970-6. PubMed ID: 22240402
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
    Chan HM, Duran SH, Walz PH, Ravis WR.
    J Vet Pharmacol Ther; 2009 Jun 05; 32(3):235-40. PubMed ID: 19646087
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.